rhPDGF-BB (Augment) is a safe alternative to autologous graft in foot and ankle fusion
Prospective, Randomized, Multi-Center Feasibility Trial of rhPDGF-BB Versus Autologous Bone Graft in a Foot and Ankle Fusion ModelFoot Ankle Int. 2011 Apr;32(4):344-54.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
20 patients requiring hindfoot fusion were randomized to receive either a biosynthetic bone graft substitute (Augment Bone Graft, a recombinant form of platelet-derived growth factor (rhPDGF-BB)) or an autologous bone graft (ABG), in order to compare safety and efficacy between the two graft types. The results of this study suggest the biosynthetic bone graft is a safe and efficacious alternative ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE